BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 124022
Published online Nov 15, 2026. doi: 10.4251/wjgo.124022
Table 3 Treatment-related adverse events in the two groups, n (%)
Adverse events
Control group (n = 92)
Experimental group (n = 31)
P value
Myelosuppression49 (53.26)18 (58.06)0.798
Nausea27 (29.35)13 (41.94)0.284
Diarrhea18 (19.57)7 (22.58)0.918
Fatigue18 (19.57)6 (19.35)1.000
Proteinuria16 (17.39)3 (9.68)0.397
Hypertension7 (7.61)5 (16.13)0.302
Hepatic dysfunction24 (26.09)10 (32.26)0.666
Thyroid dysfunction13 (14.13)7 (22.58)0.411
Hand-foot syndrome8 (8.70)2 (6.45)1.000
rCCEP0 (0.00)16 (51.61)< 0.001


Write to the Help Desk